Addex Therapeutics Ltd
ADXN8.000USD
-0.380-4.53%
收盘 12/24, 13:00（美东）报价延迟15分钟
7.77M总市值
亏损市盈率 TTM
关于 Addex Therapeutics Ltd 公司
Addex Therapeutics Ltd is a Switzerland-based clinical-stage pharmaceutical company. The Company focuses on development and commercialization of orally available small molecule drugs known as allosteric modulators for neurological disorders. The Company’s clinical programs pipeline include dipraglurant (mGlu5 NAM), which is Phase 2a placebo-controlled clinical trial for Parkinson's disease levodopa-induced dyskinesia (PD-LID), and is being prepared to enter registration trials for PD-LID, and ADX71149 (mGlu2 positive allosteric modulator or PAM), which is being developed in collaboration by its partner Janssen Pharmaceuticals, Inc to treat schizophrenia and anxious depression. It also is advancing several preclinical programs, including GABABPAM for pain, overactive bladder and other disorders, mGlu7 NAM for post-traumatic stress disorder, mGlu2 NAM for mild neurocognitive disorders, mGlu4 PAM for Parkinson’s disease and mGlu3 PAM for neurodegenerative disorders.
Addex Therapeutics Ltd简介
公司代码ADXN
公司名称Addex Therapeutics Ltd
上市日期May 22, 2007
CEODyer (Tim)
员工数量2
证券类型Depository Receipt
年结日May 22
公司地址Chemin des Mines, 9
城市PLAN-LES-OUATES
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Switzerland
邮编1202
电话41228841555
网址https://www.addextherapeutics.com/en/
公司代码ADXN
上市日期May 22, 2007
CEODyer (Tim)
Addex Therapeutics Ltd公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Mikhail Kalinichev
Dr. Mikhail Kalinichev
Member of the Executive Management, Head of Translational Science
Member of the Executive Management, Head of Translational Science
--
--
Dr. Raymond G. (Ray) Hill
Dr. Raymond G. (Ray) Hill
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Mr. Lenaic Teyssedou
Mr. Lenaic Teyssedou
Member of the Executive Management, Head of Finance
Member of the Executive Management, Head of Finance
--
--
Dr. Vincent Lawton
Dr. Vincent Lawton
Independent Non-Executive Chairman of the Board of Directors
Independent Non-Executive Chairman of the Board of Directors
--
--
Mr. Jake R. Nunn
Mr. Jake R. Nunn
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Mr. Tim Dyer
Mr. Tim Dyer
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
--
--
Dr. Isaac Manke
Dr. Isaac Manke
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Dr. Roger G. Mills
Dr. Roger G. Mills
Member of the Executive Management, Chief Medical Officer, Member of the Board of Directors
Member of the Executive Management, Chief Medical Officer, Member of the Board of Directors
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Mikhail Kalinichev
Dr. Mikhail Kalinichev
Member of the Executive Management, Head of Translational Science
Member of the Executive Management, Head of Translational Science
--
--
Dr. Raymond G. (Ray) Hill
Dr. Raymond G. (Ray) Hill
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Mr. Lenaic Teyssedou
Mr. Lenaic Teyssedou
Member of the Executive Management, Head of Finance
Member of the Executive Management, Head of Finance
--
--
Dr. Vincent Lawton
Dr. Vincent Lawton
Independent Non-Executive Chairman of the Board of Directors
Independent Non-Executive Chairman of the Board of Directors
--
--
Mr. Jake R. Nunn
Mr. Jake R. Nunn
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Mr. Tim Dyer
Mr. Tim Dyer
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
--
--
收入明细
由于公司未披露，未能获取相关数据
由于公司未披露，未能获取相关数据
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 11月15日 周六
更新时间: 11月15日 周六
持股股东
股东类型
持股股东
持股股东
占比
GAMMA Investing LLC
0.01%
其他
99.99%
持股股东
持股股东
占比
GAMMA Investing LLC
0.01%
其他
99.99%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
0.01%
其他
99.99%
机构持股
更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
11
199.00
18.66%
--
2025Q3
13
199.00
18.82%
-178.00
2025Q2
13
377.00
18.92%
-12.73K
2025Q1
16
13.11K
17.74%
-176.53K
2024Q4
18
15.10K
16.53%
+13.71K
2024Q3
23
37.43K
17.28%
-1.01K
2024Q2
22
38.45K
22.31%
+2.01K
2024Q1
21
36.44K
17.06%
-145.91K
2023Q4
20
195.87K
5.59%
+122.48K
2023Q3
19
73.39K
85.88%
+23.16K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
GAMMA Investing LLC
121.00
0.01%
--
--
Sep 30, 2025
Rhumbline Advisers Ltd. Partnership
72.00
0.01%
--
--
Jun 30, 2025
SBI Securities Co., Ltd.
5.00
0%
--
--
Jun 30, 2025
UBS Financial Services, Inc.
--
0%
-4.00
-100.00%
Dec 31, 2023
Citadel Advisors LLC
--
0%
-11.74K
-100.00%
Jun 30, 2025
Morgan Stanley & Co. LLC
100.00
0.01%
--
--
Jun 30, 2025
J. Stern & Co. LLP
--
0%
-107.83K
-100.00%
Mar 31, 2024
Armistice Capital LLC
--
0%
-43.00K
-100.00%
Mar 31, 2024
New Enterprise Associates (NEA)
--
0%
-9.00K
-100.00%
Mar 31, 2024
Adar1 Capital Management LLC
--
0%
-1.00K
-100.00%
Dec 31, 2024
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Oct 06, 2023
Merger
20→1
Oct 06, 2023
Merger
20→1
Oct 06, 2023
Merger
20→1
Oct 06, 2023
Merger
20→1
公告日期
类型
比率
Oct 06, 2023
Merger
20→1
Oct 06, 2023
Merger
20→1
Oct 06, 2023
Merger
20→1
Oct 06, 2023
Merger
20→1
常见问题
Addex Therapeutics Ltd的前五大股东是谁？
Addex Therapeutics Ltd 的前五大股东如下：
GAMMA Investing LLC持有股份：121.00，占总股份比例：0.01%。
Rhumbline Advisers Ltd. Partnership持有股份：72.00，占总股份比例：0.01%。
SBI Securities Co., Ltd.持有股份：5.00，占总股份比例：0.00%。
UBS Financial Services, Inc.持有股份：0.00，占总股份比例：0.00%。
Citadel Advisors LLC持有股份：0.00，占总股份比例：0.00%。
GAMMA Investing LLC持有股份：121.00，占总股份比例：0.01%。
Rhumbline Advisers Ltd. Partnership持有股份：72.00，占总股份比例：0.01%。
SBI Securities Co., Ltd.持有股份：5.00，占总股份比例：0.00%。
UBS Financial Services, Inc.持有股份：0.00，占总股份比例：0.00%。
Citadel Advisors LLC持有股份：0.00，占总股份比例：0.00%。
Addex Therapeutics Ltd的前三大股东类型是什么？
Addex Therapeutics Ltd 的前三大股东类型分别是：
GAMMA Investing LLC
其他
GAMMA Investing LLC
其他
有多少机构持有Addex Therapeutics Ltd(ADXN)的股份？
截至2025Q4，共有11家机构持有Addex Therapeutics Ltd的股份，合计持有的股份价值约为199.00，占公司总股份的18.66%。与2025Q3相比，机构持股有所增加，增幅为-0.16%。
哪个业务部门对Addex Therapeutics Ltd的收入贡献最大？
在--，--业务部门对Addex Therapeutics Ltd的收入贡献最大，创收--，占总收入的--%。
